‘No evidence of disease activity’ for Ocrelizab patients
Posted: Fri Apr 22, 2016 1:14 am
‘No evidence of disease activity’ for multiple sclerosis patients on Ocrelizumab
Patients with multiple sclerosis (MS) taking Ocrelizumab are more likely to achieve no evidence of disease activity (NEDA) than those taking beta interferon, researchers from the pivotal OPERA I and OPERA II phase III trials have reported...Read more - http://www.ms-uk.org/MSnews
Patients with multiple sclerosis (MS) taking Ocrelizumab are more likely to achieve no evidence of disease activity (NEDA) than those taking beta interferon, researchers from the pivotal OPERA I and OPERA II phase III trials have reported...Read more - http://www.ms-uk.org/MSnews